• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种针对由 Parkin 基因突变引起的常染色体隐性遗传少年型帕金森病的剪接干预治疗。

A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations.

机构信息

Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth 6150, Australia.

Perron Institute for Neurological and Translational Science, University of Western Australia, Perth 6009, Australia.

出版信息

Int J Mol Sci. 2020 Oct 1;21(19):7282. doi: 10.3390/ijms21197282.

DOI:10.3390/ijms21197282
PMID:33019779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7582384/
Abstract

Parkin-type autosomal recessive juvenile-onset Parkinson's disease is caused by mutations in the gene and accounts for 50% of all autosomal recessive Parkinsonism cases. Parkin is a neuroprotective protein that has dual functions as an E3 ligase in the ubiquitin-proteasome system and as a transcriptional repressor of . While genomic deletions of exon 3 disrupt the mRNA reading frame and result in the loss of functional parkin protein, deletions of both exon 3 and 4 maintain the reading frame and are associated with a later onset, milder disease progression, indicating this particular isoform retains some function. Here, we describe in vitro evaluation of antisense oligomers that restore functional parkin expression in cells derived from a Parkinson's patient carrying a heterozygous exon 3 deletion, by inducing exon 4 skipping to correct the reading frame. We show that the induced transcript is translated into a shorter but semi-functional parkin isoform able to be recruited to depolarised mitochondria, and also transcriptionally represses expression. These results support the potential use of antisense oligomers as a disease-modifying treatment for selected pathogenic mutations.

摘要

Parkin 型常染色体隐性少年型帕金森病是由 基因突变引起的,占所有常染色体隐性帕金森病病例的 50%。Parkin 是一种神经保护蛋白,具有泛素蛋白酶体系统中 E3 连接酶和 的转录抑制剂的双重功能。虽然 外显子 3 的基因组缺失破坏了 mRNA 的阅读框,导致功能性 Parkin 蛋白丢失,但外显子 3 和 4 的缺失保持了阅读框,并与发病较晚、疾病进展较轻相关,表明这种特殊的异构体保留了一些功能。在这里,我们描述了体外评估反义寡核苷酸的结果,这些寡核苷酸通过诱导外显子 4 跳跃来纠正阅读框,从而恢复携带杂合 外显子 3 缺失的帕金森病患者来源细胞中的功能性 Parkin 表达。我们表明,诱导的 转录本被翻译成较短但半功能的 Parkin 异构体,能够被募集到去极化的线粒体,并抑制 的转录表达。这些结果支持将反义寡核苷酸作为一种有潜力的疾病修饰治疗方法,用于治疗特定的致病性 突变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/5dab8e4315a7/ijms-21-07282-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/6eb6f8662f3c/ijms-21-07282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/dd683eb1e49c/ijms-21-07282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/58cb046018e3/ijms-21-07282-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/630d3629d411/ijms-21-07282-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/5dab8e4315a7/ijms-21-07282-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/6eb6f8662f3c/ijms-21-07282-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/dd683eb1e49c/ijms-21-07282-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/58cb046018e3/ijms-21-07282-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/630d3629d411/ijms-21-07282-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/75fa/7582384/5dab8e4315a7/ijms-21-07282-g005.jpg

相似文献

1
A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson's Disease Arising from Parkin Mutations.一种针对由 Parkin 基因突变引起的常染色体隐性遗传少年型帕金森病的剪接干预治疗。
Int J Mol Sci. 2020 Oct 1;21(19):7282. doi: 10.3390/ijms21197282.
2
Naturally- and experimentally-designed restorations of the Parkin gene deficit in autosomal recessive juvenile parkinsonism.自然和实验设计的常染色体隐性遗传少年型帕金森病 Parkin 基因缺陷修复。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):800-5. doi: 10.1016/j.bbrc.2009.11.141. Epub 2009 Nov 27.
3
Parkin mutations and early-onset parkinsonism in a Taiwanese cohort.台湾人群中的帕金基因突变与早发性帕金森病
Arch Neurol. 2005 Jan;62(1):82-7. doi: 10.1001/archneur.62.1.82.
4
Detection of compound heterozygous deletions in the parkin gene of fibroblasts in patients with autosomal recessive hereditary parkinsonism (PARK2).常染色体隐性遗传性帕金森病(PARK2)患者成纤维细胞中帕金基因复合杂合缺失的检测
Neurosci Lett. 2006 May 29;400(1-2):44-7. doi: 10.1016/j.neulet.2006.02.035. Epub 2006 Mar 6.
5
Efficient exon skipping of SGCG mutations mediated by phosphorodiamidate morpholino oligomers.磷酸二酰胺吗啉寡聚物介导的 SGCG 突变的有效外显子跳跃。
JCI Insight. 2018 May 3;3(9):99357. doi: 10.1172/jci.insight.99357.
6
Association between early-onset Parkinson's disease and mutations in the parkin gene.早发性帕金森病与帕金基因(parkin gene)突变之间的关联。
N Engl J Med. 2000 May 25;342(21):1560-7. doi: 10.1056/NEJM200005253422103.
7
Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy.定量反义筛选和优化用于杜氏肌营养不良症外显子 51 跳跃。
Mol Ther. 2017 Nov 1;25(11):2561-2572. doi: 10.1016/j.ymthe.2017.07.014. Epub 2017 Jul 28.
8
Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations.帕金森病伴 parkin 基因突变患者皮肤成纤维细胞中的转录异常。
Neurobiol Aging. 2018 May;65:206-216. doi: 10.1016/j.neurobiolaging.2018.01.021. Epub 2018 Feb 7.
9
Long-Read Sequencing Resolves a Complex Structural Variant in PRKN Parkinson's Disease.长读测序解析 PRKN 帕金森病中的复杂结构变异。
Mov Disord. 2023 Dec;38(12):2249-2257. doi: 10.1002/mds.29610. Epub 2023 Nov 5.
10
A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease.在欧洲,帕金森病基因(parkin基因)中的多种突变是常染色体隐性帕金森综合征的病因。法国帕金森病遗传学研究小组和欧洲帕金森病遗传易感性联盟。
Hum Mol Genet. 1999 Apr;8(4):567-74. doi: 10.1093/hmg/8.4.567.

引用本文的文献

1
Expansion of Splice-Switching Therapy with Antisense Oligonucleotides.反义寡核苷酸介导的剪接转换疗法的扩展
Int J Mol Sci. 2025 Mar 4;26(5):2270. doi: 10.3390/ijms26052270.
2
Antisense oligonucleotides and their applications in rare neurological diseases.反义寡核苷酸及其在罕见神经系统疾病中的应用。
Front Neurosci. 2024 Sep 23;18:1414658. doi: 10.3389/fnins.2024.1414658. eCollection 2024.
3
Genotype-phenotype correlation in PRKN-associated Parkinson's disease.PRKN相关帕金森病的基因型-表型相关性

本文引用的文献

1
Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.系统方法开发剪接调节反义寡核苷酸。
Int J Mol Sci. 2019 Oct 11;20(20):5030. doi: 10.3390/ijms20205030.
2
Mechanism of parkin activation by PINK1.Parkin 的激活机制由 PINK1 介导。
Nature. 2018 Jul;559(7714):410-414. doi: 10.1038/s41586-018-0224-x. Epub 2018 Jun 6.
3
Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs.反义寡核苷酸和双链 RNA 的化学、机制和临床状况。
NPJ Parkinsons Dis. 2024 Mar 29;10(1):72. doi: 10.1038/s41531-024-00677-3.
4
Genetic study of a Chinese pedigree with early onset Parkinson's disease caused by novel compound heterozygous mutations in gene.一个由基因中新型复合杂合突变导致早发性帕金森病的中国家系的遗传学研究。
Ibrain. 2021 Jun 28;7(2):108-112. doi: 10.1002/j.2769-2795.2021.tb00072.x. eCollection 2021 Jun.
5
miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson's disease.基于微小RNA和反义寡核苷酸的α-突触核蛋白靶向治疗作为帕金森病的疾病修饰疗法
Front Pharmacol. 2022 Nov 15;13:1034072. doi: 10.3389/fphar.2022.1034072. eCollection 2022.
6
Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?帕金森病的靶向分子疗法:反义寡核苷酸的作用?
Mov Disord. 2022 Nov;37(11):2184-2190. doi: 10.1002/mds.29201. Epub 2022 Aug 29.
7
Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy.反义寡核苷酸介导的外显子跳跃疗法:从杜氏肌营养不良症蔓延开来的精准医学
JMA J. 2021 Jul 15;4(3):232-240. doi: 10.31662/jmaj.2021-0019. Epub 2021 Jul 9.
8
Nucleic Acid-Based Therapeutics in Orphan Neurological Disorders: Recent Developments.罕见神经系统疾病的核酸疗法:最新进展
Front Mol Biosci. 2021 Apr 28;8:643681. doi: 10.3389/fmolb.2021.643681. eCollection 2021.
Nucleic Acids Res. 2018 Feb 28;46(4):1584-1600. doi: 10.1093/nar/gkx1239.
4
Reactive oxygen species trigger Parkin/PINK1 pathway-dependent mitophagy by inducing mitochondrial recruitment of Parkin.活性氧通过诱导Parkin的线粒体募集来触发Parkin/PINK1途径依赖性线粒体自噬。
J Biol Chem. 2017 Oct 6;292(40):16697-16708. doi: 10.1074/jbc.M117.787739. Epub 2017 Aug 28.
5
Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease.α-突触核蛋白:帕金森病中的病理学、线粒体功能障碍和神经炎症。
Neurobiol Dis. 2018 Jan;109(Pt B):249-257. doi: 10.1016/j.nbd.2017.04.004. Epub 2017 Apr 8.
6
FDA-Approved Oligonucleotide Therapies in 2017.2017年美国食品药品监督管理局批准的寡核苷酸疗法
Mol Ther. 2017 May 3;25(5):1069-1075. doi: 10.1016/j.ymthe.2017.03.023. Epub 2017 Mar 31.
7
Altered Mitochondrial Respiration and Other Features of Mitochondrial Function in Parkin-Mutant Fibroblasts from Parkinson's Disease Patients.帕金森病患者帕金基因突变成纤维细胞中线粒体呼吸及线粒体功能其他特征的改变
Parkinsons Dis. 2016;2016:1819209. doi: 10.1155/2016/1819209. Epub 2016 Mar 8.
8
Genomics in rugby union: A review and future prospects.英式橄榄球联盟中的基因组学:综述与未来展望。
Eur J Sport Sci. 2015;15(6):460-8. doi: 10.1080/17461391.2015.1023222. Epub 2015 Mar 23.
9
Parkin structure and function.帕金蛋白的结构与功能。
FEBS J. 2015 Jun;282(11):2076-88. doi: 10.1111/febs.13249. Epub 2015 Mar 16.
10
Parkin sensitizes toward apoptosis induced by mitochondrial depolarization through promoting degradation of Mcl-1.帕金蛋白通过促进Mcl-1的降解,使细胞对线粒体去极化诱导的细胞凋亡敏感。
Cell Rep. 2014 Nov 20;9(4):1538-53. doi: 10.1016/j.celrep.2014.10.046. Epub 2014 Nov 13.